STOCK TITAN

CURE PHARMACEUTICAL HOLDING COR - CURR STOCK NEWS

Welcome to our dedicated page for CURE PHARMACEUTICAL HOLDING COR news (Ticker: CURR), a resource for investors and traders seeking the latest updates and insights on CURE PHARMACEUTICAL HOLDING COR stock.

CURE PHARMACEUTICAL HOLDING COR (symbol: CURR), now known as Avenir Wellness Solutions, Inc., is at the forefront of innovative drug delivery and development. The company is dedicated to enhancing drug efficacy, safety, and the overall patient experience through its proprietary drug dosage forms and delivery systems. Avenir boasts an industry-leading full-service CGMP manufacturing facility and is renowned for its advanced oral thin film, Curefilm™, the most sophisticated oral thin film available today.

With a strong presence in the pharmaceutical cannabis sector and partnerships in the U.S., Canada, Israel, and Germany, Avenir is committed to improving how medicines are delivered and experienced worldwide. The company has developed a broad range of products using cutting-edge delivery platforms and collaborates with leading pharmaceutical companies.

Recently, Avenir has experienced significant growth, as evidenced by its financial performance. In the first quarter of 2023, the company reported a 15.1% increase in net revenue year-over-year and a 35.6% sequential increase from Q4 2022, reaching $1.2 million. Gross margins improved by 102 basis points to 78.9%, with further increases expected.

The company's strategic initiatives, including cost reductions and operating leverage, are expected to help narrow the net operating loss from continuing operations, excluding non-cash charges. Avenir's advertising and marketing campaigns, especially for its new product, DNA Complex, have garnered positive attention from prominent media outlets.

On August 9, 2023, the company officially changed its ticker symbol to AVRW and its corporate name to Avenir Wellness Solutions, reflecting its renewed focus on wellness technologies and high-margin products. The rebranding aligns with Avenir's long-term growth strategy to increase revenue through product development, strategic partnerships, and geographic licensing deals.

For more information, visit the company's website at avenirwellness.com.

Rhea-AI Summary
Avenir Wellness Solutions, Inc. (AVRW) announced encouraging results for the third fiscal quarter of 2023, with net revenue increasing sequentially to $1.0 million. Gross margin expanded by 80 basis points quarter-to-quarter, although it decreased by 740 basis points year-over-year. SG&A expenses decreased by $721 thousand, and the net operating loss improved by $30 thousand. The company's new beauty subscription program and DNA Complex hero product have shown significant growth, and the company regained compliance with the OTCQB Standards.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Avenir Wellness Solutions, Inc. has received regulatory approval to change its ticker symbol from 'CURR' to 'AVRW' effective August 9, 2023. The name change reflects the company's focus on wellness technology and its efforts to create and commercialize quality products and brands in the wellness and beauty space. The company aims to increase revenue with high-margin products and grow its shareholder value through innovative technologies and strategic partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8%
Tags
none
-
Rhea-AI Summary
Avenir Wellness Solutions, Inc. (OTC:CURR) announced encouraging results for the first quarter of 2023. The company reported a 15.1% year-over-year increase in net revenue, with gross margins improving by 102 basis points to 78.9%. Despite increased SG&A expenses, the net operating loss decreased by $0.5 million. The launch of new products and marketing initiatives are expected to contribute to further revenue growth and high margin sales. Avenir's new product, DNA Complex, received positive coverage from prominent sources after its launch.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.77%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.14%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.06%
Tags
none

FAQ

What does Cure Pharmaceutical Holding Corp. do?

Cure Pharmaceutical Holding Corp., now Avenir Wellness Solutions, develops and delivers innovative drug dosage forms and delivery systems to improve drug efficacy, safety, and patient experience.

What is Curefilm™?

Curefilm™ is Avenir Wellness Solutions' proprietary and advanced oral thin film, designed to enhance drug delivery and effectiveness.

What are the financial highlights for the first quarter of 2023?

In Q1 2023, Avenir reported a 15.1% increase in net revenue year-over-year and a 35.6% sequential increase from Q4 2022, reaching $1.2 million.

What recent changes has Avenir made to its corporate structure?

On August 9, 2023, the company changed its ticker symbol to AVRW and its name to Avenir Wellness Solutions to reflect its focus on wellness technologies.

What is Avenir's mission?

Avenir's mission is to improve people's lives by redefining how medicines are delivered and experienced.

How has Avenir's marketing strategy impacted their business?

Avenir's marketing campaigns, particularly for DNA Complex, have received positive media attention, helping to increase brand recognition and sales.

What markets does Avenir operate in?

Avenir operates in the U.S., Canada, Israel, and Germany, particularly in the pharmaceutical cannabis sector.

Who are Avenir's notable partners?

Avenir collaborates with leading pharmaceutical companies and has formed partnerships in various markets worldwide.

What is the significance of the name change to Avenir Wellness Solutions?

The name change to Avenir Wellness Solutions reflects the company's renewed focus on developing and commercializing wellness technologies.

Where can I find more information about Avenir's financial performance?

You can visit Avenir's website at avenirwellness.com to review the most recent financial reports and updates.

CURE PHARMACEUTICAL HOLDING COR

OTC:CURR

CURR Rankings

CURR Stock Data

7.85M
48.81M
30.38%
0.27%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States
Sherman Oaks